Tecvayli Injection
Product Images NDC 57894-449

4 FDA label images from Janssen Biotech, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tecvayli (NDC 57894-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tecvayli 01)

Figure 1 (Tecvayli 01)
Packaging label for TECVAYLI (teclistamab-cqyv) injection, 30 mg/3 mL (10 mg/mL) strength. The label specifies it as a single-dose vial for subcutaneous injection, intended for use by healthcare providers only. It includes storage instructions to refrigerate at 2°C to 8°C and contains no preservatives. Manufactured by Janssen Biotech, Inc., with a warning not to combine vials of different concentrations to achieve a treatment dose.*
FDA Label Image

Figure 2 (Tecvayli 02)

Figure 2 (Tecvayli 02)
Label for TECVAYLI (teclistamab-cqyv) injection, 153 mg/1.7 mL (90 mg/mL) strength. The label indicates it is a single-dose vial for subcutaneous injection, for use by healthcare providers only. It includes storage instructions to refrigerate at 2°C to 8°C and contains no preservative. Manufactured by Janssen Biotech, Inc., Horsham, PA, USA.*
FDA Label Image

Principal Display Panel (30 mg/3 mL Vial Carton)

Principal Display Panel (30 mg/3 mL Vial Carton)
Packaging label for TECVAYLI (teclistamab-cqyv) injection, a subcutaneous injection available at 30 mg/3 mL (10 mg/mL) strength. The box includes information for a single-dose vial, manufactured by Janssen Biotech, Inc. It contains storage instructions, dosage recommendations, and barcodes. The label highlights that TECVAYLI vials of different concentrations should not be combined.*
FDA Label Image

Principal Display Panel (153 mg/1.7 mL Vial Carton)

Principal Display Panel (153 mg/1.7 mL Vial Carton)
Carton label for TECVAYLI (teclistamab-cqyv) injection, 153 mg/1.7 mL (90 mg/mL) strength. The label indicates this is a single-dose vial for subcutaneous injection by a healthcare provider only, with instructions to discard unused portions. Manufactured by Janssen Biotech, Inc., with storage instructions to keep refrigerated between 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. No preservative included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.